3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
5
Seizures
4
Marijuana Abuse
3
Colonic Neoplasms
3
Breast Neoplasms
3
Sturge-Weber Syndrome
2
Nausea
2
Lennox Gastaut Syndrome
2
Glioblastoma
2
Epilepsies, Myoclonic
2
Anxiety Disorders
2
Vomiting
1
Tuberous Sclerosis 2
1
Tuberous Sclerosis 1
1
Spasms, Infantile
1
Solid Tumor
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Parasomnias
1
Pancreatic Neoplasms
1
Pain
1
Neoplasms
1
Multiple Myeloma
1
Liver Neoplasms
1
Liver Cirrhosis
1
Gallbladder Neoplasms
1
Epilepsy
1
Dysgeusia
1
Drug Resistant Epilepsy
1
Colorectal Neoplasms
1
Interventions
Melatonin
4
Surveys and Questionnaires
3
Yoga
2
Exercise
2
Control Groups
2
nabiximols
1
Walking
1
Ultraviolet Therapy
1
Tai Ji
1
Sugars
1
Respiration
1
Relaxation Therapy
1
Qigong
1
Modafinil
1
Minocycline
1
Mindfulness
1
Midazolam
1
Massage
1
Intensive Care Units
1
Exercise Movement Techniques
1
Dronabinol
1
Cannabidiol
1
Breathing Exercises
1
Autogenic Training
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Parasomnias
×
Cannabidiol
×
Clear all
NCT03948074
2025-09-10
CAFCARS
British Columbia Cancer Agency
Phase 2
Completed
91 enrolled